Use of Bestatin, a well-known LTA4H inhibitor or LTA4H silencing induced proliferation arrest in KSHV+ PEL cells when compared to non-infected (KSHV–; BJAB) Burkitt’s lymphoma cells. The gene discussed is LTA4H; the disease is Burkitt lymphoma.